-       Report 
   - August 2025
    -  73 Pages 
    Middle East, Africa
   
   From       €3101EUR$3,450USD£2,720GBP 
                -       Report 
   - August 2025
    -  97 Pages 
    Asia Pacific
   
   From       €3550EUR$3,950USD£3,114GBP 
                -       Report 
   - August 2025
    -  98 Pages 
    Europe
   
   From       €3550EUR$3,950USD£3,114GBP 
                -       Report 
   - August 2025
    -  89 Pages 
    North America
   
   From       €3101EUR$3,450USD£2,720GBP 
                -       Report 
   - February 2024
    -  280 Pages 
    Global
   
   From       €5134EUR$5,912USD£4,350GBP 
                 -       Report 
   - December 2022
    -  120 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - March 2024
    -  200 Pages 
    Global
   
   From       €3730EUR$4,150USD£3,271GBP 
                -       Report 
   - October 2023
    -  145 Pages 
    Global
   
   From       €2831EUR$3,150USD£2,483GBP 
                -       Report 
   - October 2023
    -  145 Pages 
    Global
   
   From       €2831EUR$3,150USD£2,483GBP 
                -       Report 
   - October 2023
    -  145 Pages 
    Global
   
   From       €2831EUR$3,150USD£2,483GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Drug Pipelines 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - June 2024
    -  238 Pages 
    Global
   
   From       €5716EUR$6,360USD£5,013GBP 
      €7146EUR$7,950USD£6,267GBP 
                  -       Report 
   - June 2024
    -  200 Pages 
    Global
   
   From       €5716EUR$6,360USD£5,013GBP 
      €7146EUR$7,950USD£6,267GBP 
                  -       Report 
   - February 2023
    -  30 Pages 
    Japan
   
   From       €1977EUR$2,200USD£1,734GBP 
      €2472EUR$2,750USD£2,168GBP 
                  -       Report 
   - February 2022
    -  269 Pages 
    Global
   
   From       €6831EUR$7,600USD£5,991GBP 
      €8539EUR$9,500USD£7,488GBP 
                -       Report 
   - February 2024
    -  114 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
                -       Report 
   - April 2023
    -  115 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
                -       Report 
   - February 2024
    -  110 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
                -       Report 
   - February 2024
    -  111 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
             
         The Dermatologicals market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin diseases, including acne, psoriasis, eczema, and skin cancer. Dermatologicals are typically administered topically, although some may be taken orally. The market is highly competitive, with a wide range of products available from both generic and branded manufacturers.
The Dermatologicals market    is driven by the increasing prevalence of skin diseases, as well as the development of new treatments and technologies. Additionally, the increasing demand for cosmetic treatments has also contributed to the growth of the market.
Some of the major companies in the Dermatologicals market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other notable players include Allergan, Galderma, and Sun Pharmaceuticals. Show Less   Read more